• Pill capsule full of gears

    UTMB drug discovery partnership awarded $56 million grant

    A $56 million grant from the National Institute of Allergy and Infectious Diseases will establish an Antiviral Drug Discovery Center for Pathogens of Pandemic Concern at UTMB.

    Read More
  • People put their hands one on top of another

    New School of Public and Population Health

    Focused on training the next generation of public health workforce, UTMB announces its newly established School of Public and Population Health

    Read More
  • Image of Nipah virus

    Scientists Develop Vaccine Against Nipah Virus

    Scientists develop a vaccine against Nipah virus, a virus with a mortality rate as high as 70 percent.

    Read More

UTMB News

UTMB researcher examines why U.S. health continues to lag behind

Dr. Neil Mehta, an associate professor in epidemiology in the School of Public and Population Health at UTMB, is a guest editor of the special supplemental issue, Why is Health in the United States Continuing to Lag Behind? “There’s no simple answer,” Mehta said. “The issue touches on the many complicated factors with a focus on social and behavioral factors.”

UTMB Partners With UT El Paso To Improve Medical Imaging

The University of Texas Medical Branch partners with UT El Paso on deep learning approach to improving lung region segmentation accuracy in chest x-ray images. The model is one of the first products created in partnership leveraging medical expertise at UTMB and computational expertise with machine learning and artificial intelligence at UT El Paso.

An image of a pill capsule full of gears

UTMB drug discovery partnership awarded $56 million grant

Thanks to a $56 million grant, the University of Texas Medical Branch and global health care company Novartis will enhance their work together to discover drugs to fight off the next pandemic. The grant comes from the National Institute of Allergy and Infectious Diseases (NIAID) and is one of nine such grants awarded by NIAID to establish Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern.

UTMB Physician Elected to the Texas Medical Association Board of Trustees

Dr. Samuel E. Mathis, associate professor in the Department of Family Medicine at the University of Texas Medical Branch, has been elected to the Texas Medical Association (TMA) Board of Trustees to represent the Young Physician Section. TMA’s House of Delegates policymaking body elected Mathis during the association’s annual conference TexMed, in Houston on April 30.

A man cluctching his chest during a heart attack

Heart attack mortality rate higher in the US compared to other high-income countries

When it comes to treating heart attacks, U.S. hospitals may have the latest tech and low readmission rates, but the country’s mortality rate is one of the highest among the nations included in a new study. The study, published May 4 in The BMJ, found substantial differences in care for heart attack patients across six high income countries despite international agreement on how heart attacks should be treated.

Therapy for Immunodeficiency Patients Shown to have anti-SARS-CoV-2 Antibodies

Researchers at the University of Texas Medical Branch recently confirmed the presence of neutralizing antibodies to SARS--COV-2 in a common subcutaneous antibody therapy (Hizentra) used to treat immunocompromised or immunodeficient patients, citing its protective benefits to the immunocompromised patient community. The findings were recently published in the Journal of Allergy and Clinical Immunology.

A group of people place their hands one on top of the other

UTMB Unveils School of Public and Population Health

Focused on training the next generation of public health workforce and improving the overall health and well-being of residents, the University of Texas Medical Branch is announcing its newly established School of Public and Population Health today.